Ensartinib Clinical Trials
5 recruitingDrug
Phase 23Phase 31Phase 11
Showing 1–5 of 5 trials
Recruiting
Phase 2
Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.
MutationLung Cancer Stage III
Sun Yat-sen University120 enrolled1 locationNCT06563999
Recruiting
Phase 1Phase 2
Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.
Solid Advanced Tumor
Betta Pharmaceuticals Co., Ltd.164 enrolled1 locationNCT07448116
Recruiting
Phase 3
Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd.202 enrolled1 locationNCT05341583
Recruiting
Phase 2
Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Hebei Medical University Fourth Hospital80 enrolled1 locationNCT05241028
Recruiting
A Real World Study of Ensartinib in Advanced ALK-positive NSCLC
Peking Union Medical College Hospital490 enrolled1 locationNCT05498064